ResMed Inc.

RMDNYSEHealthcare● Active

$196.04

+$1.72(+0.89%)

Market Cap$28.4B

P/E Ratio—

52W High$293.81

52W Low$180.27

Avg Volume1.3M

Open$196.28

Beta0.78

Free Cash Flow Financials Revenue

ResMed Inc. (RMD) Free Cash Flow & Analysis

Annual & trailing free cash flow, FCF margin, YoY change, valuation ratios, and peer context.

RMD · free cash flow · updated Jun 8, 2026

Core FCF metrics

RMD · FCF · TTM · margin & CAGR

Free cash flow was $1.66B for FY2025 (fiscal year ending 2025-06-30), up 29.2% year-over-year The FCF margin was 32.3%. Five-year CAGR stands at +19.0%.

FY2025 Free Cash Flow$1.66B▲ +29.2% YoY

Trailing 12M (TTM)$1.75Btrailing 4 quarters sum

FCF Margin32.3%$1.66B ÷ revenue

3-Year CAGR+104.2%FY2022 → FY2025

5-Year CAGR+19.0%FY2020 → FY2025

FormulaFCF = Operating Cash Flow − Capital ExpendituresTTM = trailing 4 quarters sumCAGR → N/A if either endpoint ≤ 0

Source: FMP /cash-flow-statement · SEC 10-K / 10-Q · USDUpdated: Jun 8, 2026

Annual free cash flow history

FCF ($B, upper) · YoY Growth % (lower)

Positive FCFNegative FCF

Free Cash Flow

YoY Growth %

Annual free cash flow data

RMD · free cash flow history · annual / quarterly

Fiscal YearOperating CFCapExFree Cash FlowYoY ChangeFCF Margin

FY2025Latest$1.75B(90M)$1.66B▲ +29.2%32.3%

FY2024$1.40B(115M)$1.29B▲ +130.0%27.5%

FY2023$693.3M(134M)$559.3M▲ +186.7%13.2%

FY2022$351.1M(156M)$195.1M▼ 68.5%5.5%

FY2021$736.7M(117M)$619.9M▼ 11.0%19.4%

FCF = Operating Cash Flow − Capital Expenditures · CapEx shown as (negative) · Source: SEC filings via FMP

FCF valuation metrics

RMD · P/FCF · FCF yield · FCF per share

ResMed Inc. (RMD) trades at a FCF yield of 6.17% and a price-to-free-cash-flow ratio of 16.4x. FCF per share stands at $11.96, calculated using trailing twelve-month FCF divided by basic weighted-average shares outstanding.

FCF Yield (TTM)

6.17%

Free Cash Flow ÷ Market Cap

per FMP freeCashFlowYieldTTM definition

FCF per Share (TTM)

$11.96

TTM FCF ÷ Shares Outstanding

Price / FCF

x16.4

Share Price ÷ FCF per Share

EV / FCF (TTM)

x15.7

Enterprise Value basis

Source: FMP /key-metrics-ttm · /cash-flow-statement Q · /income-statementFY2025 · 2025-06-30

Cash flow statement summary

RMD · cash flow statement · operating / investing / financing

For FY2025, ResMed Inc. generated $1.75B in operating cash flow and spent 90M in capital expenditures, yielding $1.66B in free cash flow.

Operating Activities

+$1.75B

Cash from core business operations

2025-06-30

Investing Activities

−$200.0M

CapEx, acquisitions & investments

2025-06-30

Financing Activities

−$606.3M

Buybacks, dividends & debt

2025-06-30

FCF FormulaOperating CF ($1.75B) − |CapEx| (90M) = FCF ($1.66B)

For the complete Operating / Investing / Financing line-item breakdown:

View Full Cash Flow Statement →

Free cash flow vs peers (Healthcare)

RMD vs peers · FCF

#CompanyFree Cash FlowYoYFCF MarginRelative

ResMed Inc.YOU

RMD

$1.66B+29.2%32.3%

UnitedHealth Group Incorporated

UNH

$16.07B-22.4%3.6%

82%

Eli Lilly and Company

LLY

$8.97B+2065.6%13.8%

46%

Healthcare · Sorted by FCF · FMP /cash-flow-statementFull FCF Rankings →

About Free Cash Flow & Methodology

ResMed Inc. (RMD) reported free cash flow of $1.66B for FY2025 (fiscal year ending 2025-06-30), up 29.2% year-over-year. The FCF margin was 32.3%.

Based on available data, ResMed Inc. has maintained positive free cash flow for at least 15 fiscal year(s). FCF peaked at $1.66B in FY2025. The 5-year CAGR stands at +19.0%.

ResMed Inc.'s FCF yield is 6.17% and price-to-FCF ratio is 16.4x for FY2025, based on the latest available data.

Data sourced from FMP /cash-flow-statement · SEC 10-K / 10-Q · USD.

Q&A and summaries align with SEC 10-K/10-Q cash flow disclosures and FMP /cash-flow-statement where noted.

Revenue Financial statements Net income Earnings Forecast Price history Market cap Cash on hand P/E ratio

Frequently asked questions

RMD free cash flow · 8 questions

ResMed Inc. free cash flow was $1.66B for FY2025, up 29.2% year-over-year. On a trailing twelve-month (TTM) basis, free cash flow stands at $1.75B.

RMD free cash flowRMD FCFRMD FCF 2025RMD free cash flow TTM

▸ Source: FMP /cash-flow-statement · US GAAP · ResMed Inc. · ResMed Inc. SEC 10-K & 10-Q filings · US GAAP · Last updated: Jun 8, 2026